Lung Institute | Philadelphia Pennsylvania

COPD Treatment Clinic Philadelphia

Chronic obstructive pulmonary disease (COPD) sufferers in the City of Brotherly Love can now receive treatment without leaving the state of Pennsylvania. With a relaxing train ride or at under 5-hours’ drive from Philadelphia, Pittsburgh offers cutting-edge medical treatment at prestigious healthcare facilities, as well as the opportunity to explore the city’s labor and steel industry history, fine restaurants and lodging, and and many other activities in the city where three rivers meet.  Come for the outstanding medical treatment offered in Pittsburgh, and stay on for a short vacation in a beautiful and historic Midwestern city.

COPD–Definition and Causes

COPD is a progressive form of lung disease that ranges from mild to severe. It is the restriction of airflow into and out the lungs that makes breathing difficult. COPD refers to a group of lung conditions including emphysema and chronic bronchitis. There is no cure for COPD, but with treatment options are now available relatively nearby in Pittsburgh, there has never been a better time than now to start preventing more damage to your lungs and take advantage of the opportunity to improve the quality of your life.

The primary cause of COPD is tobacco smoke. Tobacco smoke destroys tissue and causes inflammation of the lungs. Inhaled tobacco toxins saturate pulmonary passageways and air sacs (alveoli), destroying structure and elasticity. Only some of the toxins leave the body when we exhale. Unfortunately, this type of lung damage is irreversible.

On rare occasions, COPD can be caused by a genetic disorder that decreases the production of specific protein. This disorder is known as Alpha-1-antitrypsin. An alpha-1-antitrypsin deficiency may cause emphysema to develop in people who have never smoked cigarettes. Alpha-1-antitrypsin is a substance in the lungs that fights the enzyme trypsin (or protease). Trypsin is an enzyme released by immune cells in both the digestive tract and in the lungs, which fights bacteria or digests food. In people who are alpha-1-antitrypsin deficient, the lungs cannot fight the destructive nature of the trypsin. Therefore, the lung tissue is progressively weakened and destroyed, similar to what is found in a person who has smoked cigarettes.

Treating COPD

The Lung Institute state-of-the-art clinics harvest cells, the body’s natural healing system, from a patient’s own blood or bone marrow and reintroduce them into the body, directing their healing ability toward lung tissue. This high dose of cells promote healing and helps patients breathe more easily.

The Lung Institute uses autologous cells, derived from the patient’s own body for the bone marrow and the venous (blood-derived) stem cell procedures. Cells are extracted, isolated and immediately introduced back into the body where they replicate into healthy cells specialized to promote healing. All our stem cell procedures have shown anti-inflammatory properties beneficial to patients with lung disease.

The city of Pittsburgh leads lung disease research with programs like those at the Simmons Center for Interstitial Lung Disease at the University of Pittsburgh. The Pittsburgh Lung Institute clinic treats interstitial lung disease and other serious lung disorders including COPD, emphysema, chronic bronchitis, pulmonary fibrosis and black lung.

Lung disease is the third leading cause of death in the United States, and most traditional treatment options only treat the symptoms rather than the disease itself. Most who have been diagnosed with lung disease are prescribed a bronchodilator and daily medication to clear the respiratory path and reduce coughing. The advent of cellular therapy is a game-changer for those with lung disease.

Dr. Jack Coleman, Jr, MD, is the Senior Medical Director for the Lung Institute. He earned his medical degree from the University of Cincinnati as well as completed his internship and general surgery residency at the institution. Dr. Coleman is a board certified in physician and ensures that all treatments and staff will follow strict standards with the highest excellence in personalized patient care.

About the Lung Institute

At the Lung Institute, we help those with lung disease breathe easier through innovative regenerative medicine solutions. We understand the challenges that lung disease sufferers face when it comes to finding the best treatment option in order to obtain a better quality of life. With this in mind, we are committed to providing our patients with the best and most effective treatment options to bring their lives back within reach. For more information, visit our website at LungInstitute.com, like us on Facebook, Follow us on Twitter or call us today at (800) 729-3065.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.